At this rate I envisage we’ll dose cohort one by Q1 2023 and may get an early efficacy announcement…
Ann: First Patient Recruited to ACCENT Trial in Pancreatic Cancer, page-57
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.4¢ |
Change
-0.002(3.03%) |
Mkt cap ! $17.92M | |||
| Open | High | Low | Value | Volume |
| 6.6¢ | 6.7¢ | 6.4¢ | $24.34K | 370.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 122501 | 6.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.7¢ | 221265 | 1 |
View Market Depth
| Last trade - 14.47pm 17/07/2024 (20 minute delay) ? |
| ATX (ASX) Chart |